APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Gabapentin

Gabapentin is a medication used to treat epilepsy, neuropathic pain, hot flashes, and restless legs syndrome. In epilepsy, it may be used for those with partial seizures. It is recommended as one of a number of first line medications for the treatment of neuropathic pain in diabetic neuropathy, postherpetic neuralgia, and central neuropathic pain.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Gabapentin is a medication used to treat epilepsy, neuropathic pain, hot flashes, and restless legs syndrome. In epilepsy, it may be used for those with partial seizures. It is recommended as one of a number of first line medications for the treatment of neuropathic pain in diabetic neuropathy, postherpetic neuralgia, and central neuropathic pain.

Selected research

Market Analysis & Forecast

Global Gabapentin Market Analysis and Forecast 2026-2032

Report ID 173993740221 December 2025207 pages

Choose your research edition.

Industry ResearchGabapentin Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Gabapentin Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Gabapentin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gabapentin Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Gabapentin Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

Gabapentin is a medication used to treat epilepsy, neuropathic pain, hot flashes, and restless legs syndrome. In epilepsy, it may be used for those with partial seizures. It is recommended as one of a number of first line medications for the treatment of neuropathic pain in diabetic neuropathy, postherpetic neuralgia, and central neuropathic pain.

Global Gabapentin key players include Novartis, TEVA, Mylan, Pfizer, etc. Global top four manufacturers hold a share about 20%.

North America is the largest market, with a share over 30%, followed by Asia-Pacific, and Europe, both have a share about 50 percent.

Read the full market overview

In terms of product, Capsule is the largest segment, with a share about 55%. And in terms of application, the largest application is Epilepsy, followed by Neuropathic Pain, Restless Legs Syndrome, etc.

This report presents an overview of global market for Gabapentin, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Gabapentin, also provides the sales of main regions and countries. Of the upcoming market potential for Gabapentin, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Gabapentin sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Gabapentin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Gabapentin sales, projected growth trends, production technology, application and end-user industry.

Gabapentin Segment by Company

Pfizer

Assertio Therapeutics

TEVA

Mylan

Arbor Pharma

Novartis

Apotex

Sun Pharmaceutical

Aurobindo Pharma

Intas

Amneal

Marksans Pharma

Glenmark

Alkem

Jiangsu Enhua

Jiangsu Hengrui

Sailike

Gabapentin Segment by Type

Capsule

Tablet

Gabapentin Segment by Application

Epilepsy

Neuropathic Pain

Restless Legs Syndrome

Others

Gabapentin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gabapentin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gabapentin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gabapentin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Gabapentin in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Gabapentin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gabapentin sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Gabapentin Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Capsule Major Manufacturers Table 3. Tablet Major Manufacturers Table 4. Global Gabapentin Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Epilepsy Major Manufacturers Table 6. Neuropathic Pain Major Manufacturers Table 7. Restless Legs Syndrome Major Manufacturers Table 8. Others Major Manufacturers Table 9. Gabapentin Industry Trends Table 10. Gabapentin Industry Drivers Table 11. Gabapentin Industry Opportunities and Challenges Table 12. Gabapentin Industry Restraints Table 13. Global Gabapentin Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Gabapentin Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Gabapentin Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Gabapentin Revenue Market Share by Region (2021-2026) Table 17. Global Gabapentin Revenue Market Share by Region (2027-2032) Table 18. Global Gabapentin Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (M Unit) Table 19. Global Gabapentin Sales by Region (2021-2026) & (M Unit) Table 20. Global Gabapentin Sales by Region (2027-2032) & (M Unit) Table 21. Global Gabapentin Sales Market Share by Region (2021-2026) Table 22. Global Gabapentin Sales Market Share by Region (2027-2032) Table 23. Global Gabapentin Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Gabapentin Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Gabapentin Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Gabapentin Sales Market Share by Manufacturers (2021-2026) Table 27. Global Gabapentin Sales Price (USD/Unit) of Manufacturers (2021-2026) Table 28. Global Gabapentin Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Gabapentin Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Gabapentin Manufacturers, Product Type & Application Table 31. Global Gabapentin Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Gabapentin by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Gabapentin Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Gabapentin Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Gabapentin Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Gabapentin Revenue Market Share by Type (2021-2026) Table 38. Global Gabapentin Revenue Market Share by Type (2027-2032) Table 39. Global Gabapentin Sales by Type 2021 VS 2025 VS 2032 (M Unit) Table 40. Global Gabapentin Sales by Type (2021-2026) & (M Unit) Table 41. Global Gabapentin Sales by Type (2027-2032) & (M Unit) Table 42. Global Gabapentin Sales Market Share by Type (2021-2026) Table 43. Global Gabapentin Sales Market Share by Type (2027-2032) Table 44. Global Gabapentin Price by Type (2021-2026) & (USD/Unit) Table 45. Global Gabapentin Price by Type (2027-2032) & (USD/Unit) Table 46. Global Gabapentin Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Gabapentin Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Gabapentin Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Gabapentin Revenue Market Share by Application (2021-2026) Table 50. Global Gabapentin Revenue Market Share by Application (2027-2032) Table 51. Global Gabapentin Sales by Application 2021 VS 2025 VS 2032 (M Unit) Table 52. Global Gabapentin Sales by Application (2021-2026) & (M Unit) Table 53. Global Gabapentin Sales by Application (2027-2032) & (M Unit) Table 54. Global Gabapentin Sales Market Share by Application (2021-2026) Table 55. Global Gabapentin Sales Market Share by Application (2027-2032) Table 56. Global Gabapentin Price by Application (2021-2026) & (USD/Unit) Table 57. Global Gabapentin Price by Application (2027-2032) & (USD/Unit) Table 58. Pfizer Company Information Table 59. Pfizer Business Overview Table 60. Pfizer Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 61. Pfizer Gabapentin Product Portfolio Table 62. Pfizer Recent Development Table 63. Assertio Therapeutics Company Information Table 64. Assertio Therapeutics Business Overview Table 65. Assertio Therapeutics Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 66. Assertio Therapeutics Gabapentin Product Portfolio Table 67. Assertio Therapeutics Recent Development Table 68. TEVA Company Information Table 69. TEVA Business Overview Table 70. TEVA Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 71. TEVA Gabapentin Product Portfolio Table 72. TEVA Recent Development Table 73. Mylan Company Information Table 74. Mylan Business Overview Table 75. Mylan Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 76. Mylan Gabapentin Product Portfolio Table 77. Mylan Recent Development Table 78. Arbor Pharma Company Information Table 79. Arbor Pharma Business Overview Table 80. Arbor Pharma Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 81. Arbor Pharma Gabapentin Product Portfolio Table 82. Arbor Pharma Recent Development Table 83. Novartis Company Information Table 84. Novartis Business Overview Table 85. Novartis Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 86. Novartis Gabapentin Product Portfolio Table 87. Novartis Recent Development Table 88. Apotex Company Information Table 89. Apotex Business Overview Table 90. Apotex Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 91. Apotex Gabapentin Product Portfolio Table 92. Apotex Recent Development Table 93. Sun Pharmaceutical Company Information Table 94. Sun Pharmaceutical Business Overview Table 95. Sun Pharmaceutical Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 96. Sun Pharmaceutical Gabapentin Product Portfolio Table 97. Sun Pharmaceutical Recent Development Table 98. Aurobindo Pharma Company Information Table 99. Aurobindo Pharma Business Overview Table 100. Aurobindo Pharma Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 101. Aurobindo Pharma Gabapentin Product Portfolio Table 102. Aurobindo Pharma Recent Development Table 103. Intas Company Information Table 104. Intas Business Overview Table 105. Intas Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 106. Intas Gabapentin Product Portfolio Table 107. Intas Recent Development Table 108. Amneal Company Information Table 109. Amneal Business Overview Table 110. Amneal Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 111. Amneal Gabapentin Product Portfolio Table 112. Amneal Recent Development Table 113. Marksans Pharma Company Information Table 114. Marksans Pharma Business Overview Table 115. Marksans Pharma Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 116. Marksans Pharma Gabapentin Product Portfolio Table 117. Marksans Pharma Recent Development Table 118. Glenmark Company Information Table 119. Glenmark Business Overview Table 120. Glenmark Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 121. Glenmark Gabapentin Product Portfolio Table 122. Glenmark Recent Development Table 123. Alkem Company Information Table 124. Alkem Business Overview Table 125. Alkem Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 126. Alkem Gabapentin Product Portfolio Table 127. Alkem Recent Development Table 128. Jiangsu Enhua Company Information Table 129. Jiangsu Enhua Business Overview Table 130. Jiangsu Enhua Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 131. Jiangsu Enhua Gabapentin Product Portfolio Table 132. Jiangsu Enhua Recent Development Table 133. Jiangsu Hengrui Company Information Table 134. Jiangsu Hengrui Business Overview Table 135. Jiangsu Hengrui Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 136. Jiangsu Hengrui Gabapentin Product Portfolio Table 137. Jiangsu Hengrui Recent Development Table 138. Sailike Company Information Table 139. Sailike Business Overview Table 140. Sailike Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 141. Sailike Gabapentin Product Portfolio Table 142. Sailike Recent Development Table 143. North America Gabapentin Revenue by Type (2021-2026) & (US$ Million) Table 144. North America Gabapentin Revenue by Type (2027-2032) & (US$ Million) Table 145. North America Gabapentin Sales by Type (2021-2026) & (M Unit) Table 146. North America Gabapentin Sales by Type (2027-2032) & (M Unit) Table 147. North America Gabapentin Sales Price by Type (2021-2026) & (USD/Unit) Table 148. North America Gabapentin Sales Price by Type (2027-2032) & (USD/Unit) Table 149. North America Gabapentin Revenue by Application (2021-2026) & (US$ Million) Table 150. North America Gabapentin Revenue by Application (2027-2032) & (US$ Million) Table 151. North America Gabapentin Sales by Application (2021-2026) & (M Unit) Table 152. North America Gabapentin Sales by Application (2027-2032) & (M Unit) Table 153. North America Gabapentin Sales Price by Application (2021-2026) & (USD/Unit) Table 154. North America Gabapentin Sales Price by Application (2027-2032) & (USD/Unit) Table 155. North America Gabapentin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 156. North America Gabapentin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 157. North America Gabapentin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 158. North America Gabapentin Sales by Country (2021 VS 2025 VS 2032) & (M Unit) Table 159. North America Gabapentin Sales by Country (2021-2026) & (M Unit) Table 160. North America Gabapentin Sales by Country (2027-2032) & (M Unit) Table 161. North America Gabapentin Sales Price by Country (2021-2026) & (USD/Unit) Table 162. North America Gabapentin Sales Price by Country (2027-2032) & (USD/Unit) Table 163. United States Gabapentin Revenue (2021-2032) & (US$ Million) Table 164. Canada Gabapentin Revenue (2021-2032) & (US$ Million) Table 165. Mexico Gabapentin Revenue (2021-2032) & (US$ Million) Table 166. Europe Gabapentin Revenue by Type (2021-2026) & (US$ Million) Table 167. Europe Gabapentin Revenue by Type (2027-2032) & (US$ Million) Table 168. Europe Gabapentin Sales by Type (2021-2026) & (M Unit) Table 169. Europe Gabapentin Sales by Type (2027-2032) & (M Unit) Table 170. Europe Gabapentin Sales Price by Type (2021-2026) & (USD/Unit) Table 171. Europe Gabapentin Sales Price by Type (2027-2032) & (USD/Unit) Table 172. Europe Gabapentin Revenue by Application (2021-2026) & (US$ Million) Table 173. Europe Gabapentin Revenue by Application (2027-2032) & (US$ Million) Table 174. Europe Gabapentin Sales by Application (2021-2026) & (M Unit) Table 175. Europe Gabapentin Sales by Application (2027-2032) & (M Unit) Table 176. Europe Gabapentin Sales Price by Application (2021-2026) & (USD/Unit) Table 177. Europe Gabapentin Sales Price by Application (2027-2032) & (USD/Unit) Table 178. Europe Gabapentin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 179. Europe Gabapentin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 180. Europe Gabapentin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 181. Europe Gabapentin Sales by Country (2021 VS 2025 VS 2032) & (M Unit) Table 182. Europe Gabapentin Sales by Country (2021-2026) & (M Unit) Table 183. Europe Gabapentin Sales by Country (2027-2032) & (M Unit) Table 184. Europe Gabapentin Sales Price by Country (2021-2026) & (USD/Unit) Table 185. Europe Gabapentin Sales Price by Country (2027-2032) & (USD/Unit) Table 186. Germany Gabapentin Revenue (2021-2032) & (US$ Million) Table 187. France Gabapentin Revenue (2021-2032) & (US$ Million) Table 188. U.K. Gabapentin Revenue (2021-2032) & (US$ Million) Table 189. Italy Gabapentin Revenue (2021-2032) & (US$ Million) Table 190. Russia Gabapentin Revenue (2021-2032) & (US$ Million) Table 191. Spain Gabapentin Revenue (2021-2032) & (US$ Million) Table 192. Netherlands Gabapentin Revenue (2021-2032) & (US$ Million) Table 193. Switzerland Gabapentin Revenue (2021-2032) & (US$ Million) Table 194. Sweden Gabapentin Revenue (2021-2032) & (US$ Million) Table 195. Poland Gabapentin Revenue (2021-2032) & (US$ Million) Table 196. China Gabapentin Revenue by Type (2021-2026) & (US$ Million) Table 197. China Gabapentin Revenue by Type (2027-2032) & (US$ Million) Table 198. China Gabapentin Sales by Type (2021-2026) & (M Unit) Table 199. China Gabapentin Sales by Type (2027-2032) & (M Unit) Table 200. China Gabapentin Sales Price by Type (2021-2026) & (USD/Unit) Table 201. China Gabapentin Sales Price by Type (2027-2032) & (USD/Unit) Table 202. China Gabapentin Revenue by Application (2021-2026) & (US$ Million) Table 203. China Gabapentin Revenue by Application (2027-2032) & (US$ Million) Table 204. China Gabapentin Sales by Application (2021-2026) & (M Unit) Table 205. China Gabapentin Sales by Application (2027-2032) & (M Unit) Table 206. China Gabapentin Sales Price by Application (2021-2026) & (USD/Unit) Table 207. China Gabapentin Sales Price by Application (2027-2032) & (USD/Unit) Table 208. Asia Gabapentin Revenue by Type (2021-2026) & (US$ Million) Table 209. Asia Gabapentin Revenue by Type (2027-2032) & (US$ Million) Table 210. Asia Gabapentin Sales by Type (2021-2026) & (M Unit) Table 211. Asia Gabapentin Sales by Type (2027-2032) & (M Unit) Table 212. Asia Gabapentin Sales Price by Type (2021-2026) & (USD/Unit) Table 213. Asia Gabapentin Sales Price by Type (2027-2032) & (USD/Unit) Table 214. Asia Gabapentin Revenue by Application (2021-2026) & (US$ Million) Table 215. Asia Gabapentin Revenue by Application (2027-2032) & (US$ Million) Table 216. Asia Gabapentin Sales by Application (2021-2026) & (M Unit) Table 217. Asia Gabapentin Sales by Application (2027-2032) & (M Unit) Table 218. Asia Gabapentin Sales Price by Application (2021-2026) & (USD/Unit) Table 219. Asia Gabapentin Sales Price by Application (2027-2032) & (USD/Unit) Table 220. Asia Gabapentin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 221. Asia Gabapentin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 222. Asia Gabapentin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 223. Asia Gabapentin Sales by Country (2021 VS 2025 VS 2032) & (M Unit) Table 224. Asia Gabapentin Sales by Country (2021-2026) & (M Unit) Table 225. Asia Gabapentin Sales by Country (2027-2032) & (M Unit) Table 226. Asia Gabapentin Sales Price by Country (2021-2026) & (USD/Unit) Table 227. Asia Gabapentin Sales Price by Country (2027-2032) & (USD/Unit) Table 228. Japan Gabapentin Revenue (2021-2032) & (US$ Million) Table 229. South Korea Gabapentin Revenue (2021-2032) & (US$ Million) Table 230. India Gabapentin Revenue (2021-2032) & (US$ Million) Table 231. Australia Gabapentin Revenue (2021-2032) & (US$ Million) Table 232. Taiwan Gabapentin Revenue (2021-2032) & (US$ Million) Table 233. Southeast Asia Gabapentin Revenue (2021-2032) & (US$ Million) Table 234. SAMEA Gabapentin Revenue by Type (2021-2026) & (US$ Million) Table 235. SAMEA Gabapentin Revenue by Type (2027-2032) & (US$ Million) Table 236. SAMEA Gabapentin Sales by Type (2021-2026) & (M Unit) Table 237. SAMEA Gabapentin Sales by Type (2027-2032) & (M Unit) Table 238. SAMEA Gabapentin Sales Price by Type (2021-2026) & (USD/Unit) Table 239. SAMEA Gabapentin Sales Price by Type (2027-2032) & (USD/Unit) Table 240. SAMEA Gabapentin Revenue by Application (2021-2026) & (US$ Million) Table 241. SAMEA Gabapentin Revenue by Application (2027-2032) & (US$ Million) Table 242. SAMEA Gabapentin Sales by Application (2021-2026) & (M Unit) Table 243. SAMEA Gabapentin Sales by Application (2027-2032) & (M Unit) Table 244. SAMEA Gabapentin Sales Price by Application (2021-2026) & (USD/Unit) Table 245. SAMEA Gabapentin Sales Price by Application (2027-2032) & (USD/Unit) Table 246. SAMEA Gabapentin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 247. SAMEA Gabapentin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 248. SAMEA Gabapentin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 249. SAMEA Gabapentin Sales by Country (2021 VS 2025 VS 2032) & (M Unit) Table 250. SAMEA Gabapentin Sales by Country (2021-2026) & (M Unit) Table 251. SAMEA Gabapentin Sales by Country (2027-2032) & (M Unit) Table 252. SAMEA Gabapentin Sales Price by Country (2021-2026) & (USD/Unit) Table 253. SAMEA Gabapentin Sales Price by Country (2027-2032) & (USD/Unit) Table 254. Brazil Gabapentin Revenue (2021-2032) & (US$ Million) Table 255. Argentina Gabapentin Revenue (2021-2032) & (US$ Million) Table 256. Chile Gabapentin Revenue (2021-2032) & (US$ Million) Table 257. Colombia Gabapentin Revenue (2021-2032) & (US$ Million) Table 258. Peru Gabapentin Revenue (2021-2032) & (US$ Million) Table 259. Saudi Arabia Gabapentin Revenue (2021-2032) & (US$ Million) Table 260. Israel Gabapentin Revenue (2021-2032) & (US$ Million) Table 261. UAE Gabapentin Revenue (2021-2032) & (US$ Million) Table 262. Turkey Gabapentin Revenue (2021-2032) & (US$ Million) Table 263. Iran Gabapentin Revenue (2021-2032) & (US$ Million) Table 264. Egypt Gabapentin Revenue (2021-2032) & (US$ Million) Table 265. Key Raw Materials Table 266. Raw Materials Key Suppliers Table 267. Gabapentin Distributors List Table 268. Gabapentin Customers List Table 269. Research Programs/Design for This Report Table 270. Authors List of This Report Table 271. Secondary Sources Table 272. Primary Sources List of Figures Figure 1. Gabapentin Image Figure 2. Global Gabapentin Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gabapentin Market Size Share 2021 VS 2025 VS 2032 Figure 4. Capsule Image Figure 5. Tablet Image Figure 6. Global Gabapentin Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Gabapentin Market Size Share 2021 VS 2025 VS 2032 Figure 8. Epilepsy Image Figure 9. Neuropathic Pain Image Figure 10. Restless Legs Syndrome Image Figure 11. Others Image Figure 12. Global Gabapentin Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Gabapentin Revenue (2021-2032) & (US$ Million) Figure 14. Global Gabapentin Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Gabapentin Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Gabapentin Revenue Market Share by Region (2021-2032) Figure 17. Global Gabapentin Sales (2021-2032) & (M Unit) Figure 18. Global Gabapentin Sales by Region: 2021 VS 2025 VS 2032 (M Unit) Figure 19. Global Gabapentin Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Gabapentin Sales YoY (2021-2032) & (M Unit) Figure 21. Europe Gabapentin Sales YoY (2021-2032) & (M Unit) Figure 22. China Gabapentin Sales YoY (2021-2032) & (M Unit) Figure 23. Asia (Excluding China) Gabapentin Sales YoY (2021-2032) & (M Unit) Figure 24. South America, Middle East and Africa Gabapentin Sales YoY (2021-2032) & (M Unit) Figure 25. Global Gabapentin Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Gabapentin Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Gabapentin Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Gabapentin Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Gabapentin Revenue Market Share by Type (2021-2032) Figure 31. Global Gabapentin Sales by Type (2021 VS 2025 VS 2032) & (M Unit) Figure 32. Global Gabapentin Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Gabapentin Sales Market Share by Type (2021-2032) Figure 34. Global Gabapentin Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Gabapentin Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Gabapentin Revenue Market Share by Application (2021-2032) Figure 37. Global Gabapentin Sales by Application (2021 VS 2025 VS 2032) & (M Unit) Figure 38. Global Gabapentin Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Gabapentin Sales Market Share by Application (2021-2032) Figure 40. North America Gabapentin Revenue Share by Type (2021-2032) Figure 41. North America Gabapentin Sales Share by Type (2021-2032) Figure 42. North America Gabapentin Revenue Share by Application (2021-2032) Figure 43. North America Gabapentin Sales Share by Application (2021-2032) Figure 44. North America Gabapentin Revenue Share by Country (2021-2032) Figure 45. North America Gabapentin Sales Share by Country (2021-2032) Figure 46. Europe Gabapentin Revenue Share by Type (2021-2032) Figure 47. Europe Gabapentin Sales Share by Type (2021-2032) Figure 48. Europe Gabapentin Revenue Share by Application (2021-2032) Figure 49. Europe Gabapentin Sales Share by Application (2021-2032) Figure 50. Europe Gabapentin Revenue Share by Country (2021-2032) Figure 51. Europe Gabapentin Sales Share by Country (2021-2032) Figure 52. China Gabapentin Revenue Share by Type (2021-2032) Figure 53. China Gabapentin Sales Share by Type (2021-2032) Figure 54. China Gabapentin Revenue Share by Application (2021-2032) Figure 55. China Gabapentin Sales Share by Application (2021-2032) Figure 56. Asia Gabapentin Revenue Share by Type (2021-2032) Figure 57. Asia Gabapentin Sales Share by Type (2021-2032) Figure 58. Asia Gabapentin Revenue Share by Application (2021-2032) Figure 59. Asia Gabapentin Sales Share by Application (2021-2032) Figure 60. Asia Gabapentin Revenue Share by Country (2021-2032) Figure 61. Asia Gabapentin Sales Share by Country (2021-2032) Figure 62. SAMEA Gabapentin Revenue Share by Type (2021-2032) Figure 63. SAMEA Gabapentin Sales Share by Type (2021-2032) Figure 64. SAMEA Gabapentin Revenue Share by Application (2021-2032) Figure 65. SAMEA Gabapentin Sales Share by Application (2021-2032) Figure 66. SAMEA Gabapentin Revenue Share by Country (2021-2032) Figure 67. SAMEA Gabapentin Sales Share by Country (2021-2032) Figure 68. Gabapentin Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Gabapentin Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Capsule
  • Tablet
Applications
  • Epilepsy
  • Neuropathic Pain
  • Restless Legs Syndrome
  • Others
Companies covered
  • Pfizer
  • Assertio Therapeutics
  • TEVA
  • Mylan
  • Arbor Pharma
  • Novartis
  • Apotex
  • Sun Pharmaceutical
  • Aurobindo Pharma
  • Intas
  • Amneal
  • Marksans Pharma
  • Glenmark
  • Alkem
  • Jiangsu Enhua
  • Jiangsu Hengrui
  • Sailike

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Gabapentin Market by Type
  3. 1.2.1 Global Gabapentin Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Capsule
  5. 1.2.3 Tablet
  6. 1.3 Gabapentin Market by Application
  7. 1.3.1 Global Gabapentin Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Epilepsy
  9. 1.3.3 Neuropathic Pain
  10. 1.3.4 Restless Legs Syndrome
  11. 1.3.5 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Gabapentin Market Dynamics
  1. 2.1 Gabapentin Industry Trends
  2. 2.2 Gabapentin Industry Drivers
  3. 2.3 Gabapentin Industry Opportunities and Challenges
  4. 2.4 Gabapentin Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Gabapentin Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Gabapentin Revenue by Region
  3. 3.2.1 Global Gabapentin Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Gabapentin Revenue by Region (2021-2026)
  5. 3.2.3 Global Gabapentin Revenue by Region (2027-2032)
  6. 3.2.4 Global Gabapentin Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Gabapentin Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Gabapentin Sales by Region
  9. 3.4.1 Global Gabapentin Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Gabapentin Sales by Region (2021-2026)
  11. 3.4.3 Global Gabapentin Sales by Region (2027-2032)
  12. 3.4.4 Global Gabapentin Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Gabapentin Revenue by Manufacturers
  2. 4.1.1 Global Gabapentin Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Gabapentin Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Gabapentin Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Gabapentin Sales by Manufacturers
  6. 4.2.1 Global Gabapentin Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Gabapentin Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Gabapentin Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Gabapentin Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Gabapentin Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Gabapentin Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Gabapentin Manufacturers, Product Type & Application
  13. 4.7 Global Gabapentin Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Gabapentin Market CR5 and HHI
  16. 4.8.2 2025 Gabapentin Tier 1, Tier 2, and Tier 3
5 Gabapentin Market by Type
  1. 5.1 Global Gabapentin Revenue by Type
  2. 5.1.1 Global Gabapentin Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Gabapentin Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Gabapentin Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Gabapentin Sales by Type
  6. 5.2.1 Global Gabapentin Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Gabapentin Sales by Type (2021-2032) & (M Unit)
  8. 5.2.3 Global Gabapentin Sales Market Share by Type (2021-2032)
  9. 5.3 Global Gabapentin Price by Type
6 Gabapentin Market by Application
  1. 6.1 Global Gabapentin Revenue by Application
  2. 6.1.1 Global Gabapentin Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Gabapentin Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Gabapentin Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Gabapentin Sales by Application
  6. 6.2.1 Global Gabapentin Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Gabapentin Sales by Application (2021-2032) & (M Unit)
  8. 6.2.3 Global Gabapentin Sales Market Share by Application (2021-2032)
  9. 6.3 Global Gabapentin Price by Application
7 Company Profiles
  1. 7.1 Pfizer
  2. 7.1.1 Pfizer Company Information
  3. 7.1.2 Pfizer Business Overview
  4. 7.1.3 Pfizer Gabapentin Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Pfizer Gabapentin Product Portfolio
  6. 7.1.5 Pfizer Recent Developments
  7. 7.2 Assertio Therapeutics
  8. 7.2.1 Assertio Therapeutics Company Information
  9. 7.2.2 Assertio Therapeutics Business Overview
  10. 7.2.3 Assertio Therapeutics Gabapentin Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Assertio Therapeutics Gabapentin Product Portfolio
  12. 7.2.5 Assertio Therapeutics Recent Developments
  13. 7.3 TEVA
  14. 7.3.1 TEVA Company Information
  15. 7.3.2 TEVA Business Overview
  16. 7.3.3 TEVA Gabapentin Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 TEVA Gabapentin Product Portfolio
  18. 7.3.5 TEVA Recent Developments
  19. 7.4 Mylan
  20. 7.4.1 Mylan Company Information
  21. 7.4.2 Mylan Business Overview
  22. 7.4.3 Mylan Gabapentin Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Mylan Gabapentin Product Portfolio
  24. 7.4.5 Mylan Recent Developments
  25. 7.5 Arbor Pharma
  26. 7.5.1 Arbor Pharma Company Information
  27. 7.5.2 Arbor Pharma Business Overview
  28. 7.5.3 Arbor Pharma Gabapentin Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Arbor Pharma Gabapentin Product Portfolio
  30. 7.5.5 Arbor Pharma Recent Developments
  31. 7.6 Novartis
  32. 7.6.1 Novartis Company Information
  33. 7.6.2 Novartis Business Overview
  34. 7.6.3 Novartis Gabapentin Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Novartis Gabapentin Product Portfolio
  36. 7.6.5 Novartis Recent Developments
  37. 7.7 Apotex
  38. 7.7.1 Apotex Company Information
  39. 7.7.2 Apotex Business Overview
  40. 7.7.3 Apotex Gabapentin Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Apotex Gabapentin Product Portfolio
  42. 7.7.5 Apotex Recent Developments
  43. 7.8 Sun Pharmaceutical
  44. 7.8.1 Sun Pharmaceutical Company Information
  45. 7.8.2 Sun Pharmaceutical Business Overview
  46. 7.8.3 Sun Pharmaceutical Gabapentin Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Sun Pharmaceutical Gabapentin Product Portfolio
  48. 7.8.5 Sun Pharmaceutical Recent Developments
  49. 7.9 Aurobindo Pharma
  50. 7.9.1 Aurobindo Pharma Company Information
  51. 7.9.2 Aurobindo Pharma Business Overview
  52. 7.9.3 Aurobindo Pharma Gabapentin Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Aurobindo Pharma Gabapentin Product Portfolio
  54. 7.9.5 Aurobindo Pharma Recent Developments
  55. 7.10 Intas
  56. 7.10.1 Intas Company Information
  57. 7.10.2 Intas Business Overview
  58. 7.10.3 Intas Gabapentin Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Intas Gabapentin Product Portfolio
  60. 7.10.5 Intas Recent Developments
  61. 7.11 Amneal
  62. 7.11.1 Amneal Company Information
  63. 7.11.2 Amneal Business Overview
  64. 7.11.3 Amneal Gabapentin Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Amneal Gabapentin Product Portfolio
  66. 7.11.5 Amneal Recent Developments
  67. 7.12 Marksans Pharma
  68. 7.12.1 Marksans Pharma Company Information
  69. 7.12.2 Marksans Pharma Business Overview
  70. 7.12.3 Marksans Pharma Gabapentin Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Marksans Pharma Gabapentin Product Portfolio
  72. 7.12.5 Marksans Pharma Recent Developments
  73. 7.13 Glenmark
  74. 7.13.1 Glenmark Company Information
  75. 7.13.2 Glenmark Business Overview
  76. 7.13.3 Glenmark Gabapentin Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Glenmark Gabapentin Product Portfolio
  78. 7.13.5 Glenmark Recent Developments
  79. 7.14 Alkem
  80. 7.14.1 Alkem Company Information
  81. 7.14.2 Alkem Business Overview
  82. 7.14.3 Alkem Gabapentin Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Alkem Gabapentin Product Portfolio
  84. 7.14.5 Alkem Recent Developments
  85. 7.15 Jiangsu Enhua
  86. 7.15.1 Jiangsu Enhua Company Information
  87. 7.15.2 Jiangsu Enhua Business Overview
  88. 7.15.3 Jiangsu Enhua Gabapentin Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Jiangsu Enhua Gabapentin Product Portfolio
  90. 7.15.5 Jiangsu Enhua Recent Developments
  91. 7.16 Jiangsu Hengrui
  92. 7.16.1 Jiangsu Hengrui Company Information
  93. 7.16.2 Jiangsu Hengrui Business Overview
  94. 7.16.3 Jiangsu Hengrui Gabapentin Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Jiangsu Hengrui Gabapentin Product Portfolio
  96. 7.16.5 Jiangsu Hengrui Recent Developments
  97. 7.17 Sailike
  98. 7.17.1 Sailike Company Information
  99. 7.17.2 Sailike Business Overview
  100. 7.17.3 Sailike Gabapentin Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Sailike Gabapentin Product Portfolio
  102. 7.17.5 Sailike Recent Developments
8 North America
  1. 8.1 North America Gabapentin Market Size by Type
  2. 8.1.1 North America Gabapentin Revenue by Type (2021-2032)
  3. 8.1.2 North America Gabapentin Sales by Type (2021-2032)
  4. 8.1.3 North America Gabapentin Price by Type (2021-2032)
  5. 8.2 North America Gabapentin Market Size by Application
  6. 8.2.1 North America Gabapentin Revenue by Application (2021-2032)
  7. 8.2.2 North America Gabapentin Sales by Application (2021-2032)
  8. 8.2.3 North America Gabapentin Price by Application (2021-2032)
  9. 8.3 North America Gabapentin Market Size by Country
  10. 8.3.1 North America Gabapentin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Gabapentin Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Gabapentin Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Gabapentin Market Size by Type
  2. 9.1.1 Europe Gabapentin Revenue by Type (2021-2032)
  3. 9.1.2 Europe Gabapentin Sales by Type (2021-2032)
  4. 9.1.3 Europe Gabapentin Price by Type (2021-2032)
  5. 9.2 Europe Gabapentin Market Size by Application
  6. 9.2.1 Europe Gabapentin Revenue by Application (2021-2032)
  7. 9.2.2 Europe Gabapentin Sales by Application (2021-2032)
  8. 9.2.3 Europe Gabapentin Price by Application (2021-2032)
  9. 9.3 Europe Gabapentin Market Size by Country
  10. 9.3.1 Europe Gabapentin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Gabapentin Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Gabapentin Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Gabapentin Market Size by Type
  2. 10.1.1 China Gabapentin Revenue by Type (2021-2032)
  3. 10.1.2 China Gabapentin Sales by Type (2021-2032)
  4. 10.1.3 China Gabapentin Price by Type (2021-2032)
  5. 10.2 China Gabapentin Market Size by Application
  6. 10.2.1 China Gabapentin Revenue by Application (2021-2032)
  7. 10.2.2 China Gabapentin Sales by Application (2021-2032)
  8. 10.2.3 China Gabapentin Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Gabapentin Market Size by Type
  2. 11.1.1 Asia Gabapentin Revenue by Type (2021-2032)
  3. 11.1.2 Asia Gabapentin Sales by Type (2021-2032)
  4. 11.1.3 Asia Gabapentin Price by Type (2021-2032)
  5. 11.2 Asia Gabapentin Market Size by Application
  6. 11.2.1 Asia Gabapentin Revenue by Application (2021-2032)
  7. 11.2.2 Asia Gabapentin Sales by Application (2021-2032)
  8. 11.2.3 Asia Gabapentin Price by Application (2021-2032)
  9. 11.3 Asia Gabapentin Market Size by Country
  10. 11.3.1 Asia Gabapentin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Gabapentin Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Gabapentin Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Gabapentin Market Size by Type
  2. 12.1.1 SAMEA Gabapentin Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Gabapentin Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Gabapentin Price by Type (2021-2032)
  5. 12.2 SAMEA Gabapentin Market Size by Application
  6. 12.2.1 SAMEA Gabapentin Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Gabapentin Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Gabapentin Price by Application (2021-2032)
  9. 12.3 SAMEA Gabapentin Market Size by Country
  10. 12.3.1 SAMEA Gabapentin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Gabapentin Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Gabapentin Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Gabapentin Value Chain Analysis
  2. 13.1.1 Gabapentin Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Gabapentin Production Mode & Process
  6. 13.2 Gabapentin Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Gabapentin Distributors
  9. 13.2.3 Gabapentin Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst